The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 21, 2010
Filed:
Jul. 31, 2002
Samuel J. Danishefsky, Englewood, NJ (US);
Don M. Coltart, New York, NY (US);
Stacy J. Keding, New York, NY (US);
Kaustav Biswas, Thousand Oaks, CA (US);
Philip O. Livingston, New York, NY (US);
Govindaswami Ragupathi, New York, NY (US);
Jennifer R. Allen, Indianapolis, IN (US);
Lawrence Williams, Edison, NJ (US);
Samuel J. Danishefsky, Englewood, NJ (US);
Don M. Coltart, New York, NY (US);
Stacy J. Keding, New York, NY (US);
Kaustav Biswas, Thousand Oaks, CA (US);
Philip O. Livingston, New York, NY (US);
Govindaswami Ragupathi, New York, NY (US);
Jennifer R. Allen, Indianapolis, IN (US);
Lawrence Williams, Edison, NJ (US);
Sloan-Kettering Institute For Cancer Research, New York, NY (US);
Abstract
The present invention provides novel glycosides and glycoconjugates, glycoamino acids, and methods for the synthesis thereof. In another aspect, the present invention provides novel clustered glycopeptides and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, preferably for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need, an effective amount of any of the inventive glycopeptides as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier.